X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-10-14 | DRIO | Dariohealth Corp. | Cohen Oded | GM MSK | S - Sale | $16.11 | -20,000 | 430,764 | -4% | -$322,200 | ||||||
2021-10-12 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.13 | -100,000 | 4,156,248 | -2% | -$213,000 | ||||||
| D | 2021-10-13 | TNDM | Tandem Diabetes Care Inc | Morrison Susan | EVP, Chief Admin. Officer | S - Sale+OE | $132.01 | -10,048 | 8,082 | -55% | -$1,326,421 | |||||
| DM | 2021-10-12 | TNDM | Tandem Diabetes Care Inc | Vosseller Leigh | EVP, CFO | S - Sale+OE | $132.55 | -20,000 | 6,290 | -76% | -$2,650,905 | |||||
| D | 2021-10-12 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Bus Ops, Compliance | S - Sale+OE | $129.28 | -10,000 | 4,489 | -69% | -$1,292,823 | |||||
| D | 2021-10-11 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $254.60 | -14,500 | 957,582 | -1% | -$3,691,712 | |||||
| M | 2021-10-11 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.50 | +483 | 1,834,582 | 0% | +$6,038 | |||||
| M | 2021-10-07 | BTCY | Biotricity Inc. | Rosa David A | Dir | S - Sale | $3.12 | -30,027 | 125,000 | -19% | -$93,573 | |||||
| A | 2021-09-30 | ARAY | Accuray Inc | Levine Joshua | CEO | S - Sale | $3.96 | -15,741 | 1,088,480 | -1% | -$62,334 | |||||
| D | 2021-10-11 | SILK | Silk Road Medical Inc | Rogers Erica J. | Pres, CEO | S - Sale+OE | $55.73 | -11,000 | 215,879 | -5% | -$613,014 | |||||
2021-10-08 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.30 | -200,000 | 4,256,248 | -4% | -$460,000 | ||||||
2021-10-01 | RSLS | Reshape Lifesciences Inc. | Stankovich Thomas | CFO | S - Sale | $2.76 | -3,660 | 354,331 | -1% | -$10,102 | ||||||
2021-10-01 | RSLS | Reshape Lifesciences Inc. | Bandy Barton P. | Pres, CEO | S - Sale | $2.77 | -12,565 | 878,947 | -1% | -$34,805 | ||||||
| D | 2021-10-11 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $253.37 | -5,000 | 84,786 | -6% | -$1,266,850 | |||||
| D | 2021-10-08 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $79.31 | -5,000 | 89,315 | -5% | -$396,566 | |||||
2021-10-08 | NARI | Inari Medical, Inc. | Milder Donald B | Dir | S - Sale | $79.33 | -7,000 | 4,780,817 | 0% | -$555,309 | ||||||
2021-10-08 | ATRC | Atricure, Inc. | Austin Tonya | CHRO | S - Sale | $71.80 | -665 | 29,668 | -2% | -$47,747 | ||||||
| M | 2021-10-06 | ICAD | Icad Inc | Sassine Andy | Dir | S - Sale | $10.49 | -20,000 | 1,278,382 | -2% | -$209,800 | |||||
2021-10-06 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.50 | +110 | 1,834,099 | 0% | +$1,375 | ||||||
2021-10-07 | NARI | Inari Medical, Inc. | Hoffman William | Pres, CEO | S - Sale | $81.09 | -29,900 | 600,369 | -5% | -$2,424,734 | ||||||
2021-10-05 | INVO | Invo Bioscience, Inc. | Goren Andrea | CFO | P - Purchase | $3.26 | +30,674 | 93,883 | +49% | +$99,997 | ||||||
2021-10-05 | INVO | Invo Bioscience, Inc. | Shum Steve | CEO | P - Purchase | $3.26 | +30,674 | 61,924 | +98% | +$99,997 | ||||||
| D | 2021-10-05 | ANGO | Angiodynamics Inc | Campbell Chad Thomas | SVP, GM, Vascular Access | S - Sale+OE | $27.15 | -10,748 | 31,741 | -25% | -$291,808 | |||||
| M | 2021-10-05 | NARI | Inari Medical, Inc. | Hoffman William | Pres, CEO | S - Sale | $78.96 | -70,100 | 630,269 | -10% | -$5,535,370 | |||||
2021-10-05 | PETV | Petvivo Holdings, Inc. | Martin James Rudolph | Dir | P - Purchase | $2.46 | +1,600 | 86,684 | +2% | +$3,937 | ||||||
| D | 2021-10-01 | SILK | Silk Road Medical Inc | Davis Andrew S. | Chief Commercial Officer | S - Sale+OE | $53.90 | -6,324 | 70,255 | -8% | -$340,878 | |||||
| D | 2021-10-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale+OE | $261.63 | -2,500 | 51,324 | -5% | -$654,074 | |||||
2021-10-01 | PEN | Penumbra Inc | Pray James Robert | Pres, International | S - Sale | $261.73 | -5,000 | 410,009 | -1% | -$1,308,629 | ||||||
2021-10-01 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $267.06 | -634 | 11,364 | -5% | -$169,316 | ||||||
2021-10-01 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $267.06 | -80 | 4,087 | -2% | -$21,365 | ||||||
| D | 2021-10-01 | PEN | Penumbra Inc | Rothman Lynn | EVP, Chief Business Officer | S - Sale+OE | $261.70 | -5,300 | 134,444 | -4% | -$1,387,008 | |||||
2021-10-01 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $543.09 | -500 | 14,651 | -3% | -$271,547 | ||||||
| M | 2021-09-28 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.06 | -150,000 | 29,730,000 | -1% | -$8,558 | |||||
| D | 2021-10-04 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $42.92 | -201,042 | 2,081,822 | -9% | -$8,629,038 | |||||
2021-10-04 | DYNT | Dynatronics Corp | Provco Ventures 1 LP | 10% | P - Purchase | $0.00 | +26,155 | 1,049,530 | +3% | +$0 | ||||||
2021-10-04 | DYNT | Dynatronics Corp | Larkin Brian | Dir | P - Purchase | $0.00 | +2,601 | 193,372 | +1% | +$0 | ||||||
2021-10-04 | DYNT | Dynatronics Corp | Essig Stuart | 10% | P - Purchase | $0.00 | +52,338 | 1,812,703 | +3% | +$0 | ||||||
2021-10-04 | DYNT | Dynatronics Corp | Enright Erin S. | Dir | P - Purchase | $0.00 | +52,338 | 1,812,703 | +3% | +$0 | ||||||
2021-10-04 | DYNT | Dynatronics Corp | Baker Brian D. | Dir | P - Purchase | $0.00 | +3,671 | 101,632 | +4% | +$0 | ||||||
2021-10-01 | SRDX | Surmodics Inc | Maharaj Gary R | Pres, CEO | S - Sale | $56.02 | -6,000 | 152,811 | -4% | -$336,097 | ||||||
2021-10-04 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale | $260.79 | -1,487 | 122,472 | -1% | -$387,795 | ||||||
| D | 2021-10-01 | SWAV | Shockwave Medical, Inc. | Puckett Dan | CFO | S - Sale+OE | $195.47 | -2,500 | 45,788 | -5% | -$488,686 | |||||
2021-10-01 | BSX | Boston Scientific Corp | Olson Scott | SVP, Pres, Rhythm Management | S - Sale | $43.49 | -700 | 12,762 | -5% | -$30,443 | ||||||
2021-09-30 | ARAY | Accuray Inc | Levine Joshua | CEO | S - Sale | $3.96 | -15,741 | 1,088,480 | -1% | -$62,334 | ||||||
2021-10-01 | ARAY | Accuray Inc | Green Brandon W | VP, Interim CFO | S - Sale | $3.95 | -8,755 | 123,330 | -7% | -$34,582 | ||||||
| D | 2021-10-01 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Bus Ops, Compliance | S - Sale+OE | $118.00 | -1,000 | 4,489 | -18% | -$118,000 | |||||
| D | 2021-10-01 | PODD | Insulet Corp | Petrovic Shacey | Pres, CEO | S - Sale+OE | $282.87 | -15,000 | 91,079 | -14% | -$4,243,050 | |||||
2021-10-01 | RMD | Resmed Inc | Hollingshead James | Pres, Sleep Business | S - Sale | $261.33 | -2,400 | 74,479 | -3% | -$627,183 | ||||||
2021-09-28 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.48 | -200,000 | 4,456,248 | -4% | -$496,000 | ||||||
2021-09-28 | GBS | Gbs Inc. | Parmakellis Tom | Dir | P - Purchase | $2.40 | +1,000 | 2,000 | +100% | +$2,400 | ||||||
| D | 2021-09-28 | SILK | Silk Road Medical Inc | Buchanan Lucas W. | COO, CFO | S - Sale+OE | $54.86 | -10,000 | 196,173 | -5% | -$548,645 | |||||
| M | 2021-09-15 | BTCY | Biotricity Inc. | Rosa David A | Dir | S - Sale | $3.40 | -41,223 | 155,027 | -21% | -$140,336 | |||||
| D | 2021-09-27 | TNDM | Tandem Diabetes Care Inc | Leal James | SVP, Operations | S - Sale+OE | $121.72 | -1,905 | 3,751 | -34% | -$231,882 | |||||
2021-09-24 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.66 | -200,000 | 4,656,248 | -4% | -$532,000 | ||||||
| D | 2021-09-27 | NARI | Inari Medical, Inc. | Tu Thomas | Chief Medical Officer | S - Sale+OE | $82.86 | -5,000 | 48,852 | -9% | -$414,311 | |||||
2021-09-23 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.77 | -100,000 | 4,856,248 | -2% | -$277,000 | ||||||
2021-09-23 | DXCM | Dexcom Inc | Pacelli Steven Robert | Managing Dir., Dexcom Ventures | S - Sale | $573.34 | -6,743 | 41,079 | -14% | -$3,866,020 | ||||||
2021-09-22 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.80 | -100,000 | 4,956,248 | -2% | -$280,000 | ||||||
| M | 2021-09-21 | SWAV | Shockwave Medical, Inc. | Watkins Frank T | Dir | S - Sale | $219.42 | -4,000 | 63,802 | -6% | -$877,678 | |||||
2021-09-21 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.83 | -100,000 | 5,056,248 | -2% | -$283,000 | ||||||
2021-09-21 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.60 | +695 | 1,833,989 | 0% | +$8,757 | ||||||
2021-09-20 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $2.90 | -100,000 | 5,156,248 | -2% | -$290,000 | ||||||
| A | 2021-09-17 | PRCT | Procept Biorobotics Corp | Wood Morgan Colby | Dir | P - Purchase | $25.00 | +3,200 | 149,973 | +2% | +$80,000 | |||||
| D | 2021-09-21 | VAPO | Vapotherm Inc | Ramade Gregoire | SVP, Chief Commercial Officer | S - Sale+OE | $27.48 | -2,000 | 20,614 | -9% | -$54,960 | |||||
| D | 2021-09-21 | VVOS | Vivos Therapeutics, Inc. | Huntsman Ronald Kirk | CEO | P - Purchase | $4.31 | +5,000 | 1,755,500 | 0% | +$21,550 | |||||
2021-09-08 | CODX | Co-Diagnostics, Inc. | Durenard Eugene | Dir | S - Sale | $10.46 | -2,000 | 0 | -100% | -$20,910 | ||||||
| M | 2021-09-16 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $38.13 | -48,571 | 1,155,370 | -4% | -$1,852,124 | |||||
| A | 2021-09-15 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.43 | +10,000 | 1,832,048 | +1% | +$124,300 | |||||
2019-02-21 | PDEX | Pro Dex Inc | Swenson Nicholas John | Dir, 10% | S - Sale | $16.00 | -447 | 1,022,343 | 0% | -$7,152 | ||||||
2021-09-17 | NARI | Inari Medical, Inc. | Hykes Andrew | COO | S - Sale | $80.75 | -9,000 | 174,824 | -5% | -$726,742 | ||||||
2021-09-10 | RSLS | Reshape Lifesciences Inc. | Bandy Barton P. | Pres, CEO | S - Sale | $2.89 | -294,494 | 891,512 | -25% | -$851,088 | ||||||
2021-09-10 | RSLS | Reshape Lifesciences Inc. | Stankovich Thomas | CFO | S - Sale | $2.89 | -48,366 | 357,991 | -12% | -$139,778 | ||||||
2021-09-10 | RSLS | Reshape Lifesciences Inc. | Gladney Dan W | Dir | S - Sale | $2.99 | -200,000 | 283,922 | -41% | -$598,000 | ||||||
| DM | 2021-09-15 | TNDM | Tandem Diabetes Care Inc | Vosseller Leigh | EVP, CFO | S - Sale+OE | $125.00 | -10,000 | 6,290 | -61% | -$1,250,000 | |||||
| D | 2021-09-15 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Bus Ops, Compliance | S - Sale+OE | $122.00 | -9,000 | 4,489 | -67% | -$1,097,955 | |||||
2021-09-13 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.43 | +10,000 | 1,832,048 | +1% | +$124,300 | ||||||
2021-09-15 | ATRC | Atricure, Inc. | Groves Regina E | Dir | S - Sale | $74.73 | -3,156 | 16,194 | -16% | -$235,848 | ||||||
| D | 2021-09-15 | MMSI | Merit Medical Systems Inc | Wright Joseph | Pres, International | S - Sale+OE | $72.01 | -10,000 | 12,343 | -45% | -$720,100 | |||||
| D | 2021-09-15 | MMSI | Merit Medical Systems Inc | Ward Lynne | Dir | S - Sale+OE | $71.83 | -9,470 | 12,499 | -43% | -$680,230 | |||||
| DM | 2021-09-14 | MMSI | Merit Medical Systems Inc | Lloyd Brian G. | GC, Secretary | S - Sale+OE | $71.86 | -19,000 | 6,696 | -74% | -$1,365,306 | |||||
2021-09-15 | DXCM | Dexcom Inc | Sayer Kevin R | COB, CEO, Pres | S - Sale | $540.58 | -6,000 | 96,705 | -6% | -$3,243,462 | ||||||
2021-09-15 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Chief Commercial Officer | S - Sale | $220.75 | -4,000 | 55,420 | -7% | -$882,985 | ||||||
| D | 2021-09-15 | RMD | Resmed Inc | Douglas Robert Andrew | Pres, COO ResMed Inc. | S - Sale+OE | $291.83 | -8,000 | 232,556 | -3% | -$2,334,640 | |||||
| D | 2021-09-13 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $280.42 | -14,500 | 957,582 | -1% | -$4,066,037 | |||||
| M | 2021-09-13 | ICAD | Icad Inc | Sassine Andy | Dir | S - Sale | $10.89 | -20,000 | 1,298,382 | -2% | -$217,700 | |||||
2021-09-15 | BSX | Boston Scientific Corp | Carruthers Wendy | SVP, HR | S - Sale | $44.88 | -3,321 | 164,573 | -2% | -$149,046 | ||||||
| D | 2021-09-13 | TNDM | Tandem Diabetes Care Inc | Vosseller Leigh | EVP, CFO | S - Sale+OE | $120.75 | -10,000 | 6,290 | -61% | -$1,207,512 | |||||
2021-09-13 | ATRC | Atricure, Inc. | Seith Douglas J | COO | S - Sale | $75.54 | -21,444 | 64,711 | -25% | -$1,619,880 | ||||||
| D | 2021-09-13 | TNDM | Tandem Diabetes Care Inc | Hansen Brian B | EVP, CHIEF COMMERCIAL OFFICER | S - Sale+OE | $119.00 | -32,180 | 6,333 | -84% | -$3,829,337 | |||||
2021-09-13 | DXCM | Dexcom Inc | Patterson Chad | EVP, Global Marketing | S - Sale | $541.47 | -156 | 9,744 | -2% | -$84,469 | ||||||
2021-09-14 | PETV | Petvivo Holdings, Inc. | Martin James Rudolph | Dir | P - Purchase | $2.96 | +1,200 | 85,084 | +1% | +$3,552 | ||||||
| M | 2021-09-13 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.27 | +10,115 | 1,822,048 | +1% | +$124,129 | |||||
2021-09-13 | PSTV | Plus Therapeutics, Inc. | Lenk Robert P | Dir | P - Purchase | $1.86 | +7,000 | 10,000 | +233% | +$13,011 | ||||||
| D | 2021-09-14 | ICUI | Icu Medical Inc/de | Finney Elisha W | Dir | S - Sale+OE | $242.20 | -2,424 | 5,858 | -29% | -$587,096 | |||||
| D | 2021-09-13 | SILK | Silk Road Medical Inc | Rogers Erica J. | Pres, CEO | S - Sale+OE | $57.32 | -11,000 | 215,879 | -5% | -$630,565 | |||||
2021-09-13 | PDEX | Pro Dex Inc | Philp Katrina Marie Kramer | Dir | P - Purchase | $24.41 | +3,468 | 10,264 | +51% | +$84,654 | ||||||
2021-09-13 | PETV | Petvivo Holdings, Inc. | Martin James Rudolph | Dir | P - Purchase | $3.24 | +7,000 | 83,884 | +9% | +$22,665 | ||||||
2021-09-10 | ATRC | Atricure, Inc. | Austin Tonya | CHRO | S - Sale | $77.18 | -1,227 | 30,333 | -4% | -$94,700 | ||||||
2021-09-09 | AXNX | Axonics, Inc. | Cohen Raymond W | CEO | S - Sale | $77.11 | -50,000 | 234,607 | -18% | -$3,855,350 | ||||||
| M | 2021-09-09 | DXCM | Dexcom Inc | Selvaraj Shelly Ramasamy | SVP Information Technology | S - Sale | $549.00 | -2,904 | 13,014 | -18% | -$1,594,281 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |